Pfizer to discuss vaccine booster with U.S. officials Monday

Pfizer’s Dr. Mikael Dolsten told The Associated Press last week that early data from the company’s booster study suggests people’s antibody levels jump five- to 10-fold after a third dose

Share this:

FILE – In this May 11, 2021 file photo, Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, speaks during a Senate Health, Education, Labor, and Pensions hearing to examine an update from Federal officials on efforts to combat COVID-19, on Capitol Hill in Washington. Fauci said Sunday, July 11 “it is entirely conceivable, maybe likely” that Americans will need a third booster dose of the COVID-19 vaccine in the coming months, but it was too soon for the government to recommend that now. Fauci, who is President Joe Biden’s chief medical adviser, said the Centers for Disease Control and Prevention and the Food and Drug Administration did the right thing last week by pushing back against drugmaker Pfizer’s assertion about a booster within 12 months. (Jim Lo Scalzo/Pool via AP, File)
By Hope Yen | The Associated Press
PUBLISHED: July 11, 2021 at 1:48 p.m. | UPDATED: July 11, 2021 at 1:50 p.m.

Sign up for Newsletters and Alerts

Subscribe
Follow Us
Most Popular